Cholinergic Pharmacology: The Basics Flashcards

Information from M&M Notecards

1
Q

ACh Synthesis:

A

ACh is synthesized in nerve terminals by the enzyme CHOLINE ACETYLTRANSFERASE from CHOLINE and ACETYLCOENZYME A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ACh Degradation:

A

ACh is hydrolyzed by the enzyme acetylcholinesterase into:

acetate and choline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two receptor types?

A

nicotinic and muscarinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Nicotinic Receptors

A

stimulate autonomic ganglia and sk. m.

these receptors are also activated by the nicotine alkaloid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Muscarinic Receptors

A

stimulate end organ receptors

these receptors are also activated by the alkaloid muscarine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does normal muscle action work?

A

NM Transmission depends on the release of ACh from presynaptic neurons and activation of postsynaptic nicotinic cholinergic receptors on the motor end plate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do non depolarizing muscle relaxants work?

A

NM transmission is blocked by non depolarizing muscle relaxants that bind to POSTSYNAPTIC NICOTINIC cholinergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Reversal of Nondepolarizing Muscle Relaxants:

Spontaneous Reversal

A

occurs with gradual diffusion
redistribution
metabolism
and excretion of non depolarizing muscle relaxant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Reversal of Nondepolarizing Muscle Relaxants:

Pharmacologic Reversal

A

occurs with the admin of specific reversal agents

Reversal with acetylcholinesterase inhibitors should be monitored with a peripheral nerve stimulator

At least 1 twitch with TOF stim should be present before reversal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are organophosphates?

A

they are used in ophthalmology and pesticides.

they IRREVERSIBLY bind to cholinesterase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side Effects of Acetylcholinesterase Inhibitors

A

in addition to increasing the availability of acetylcholine at the NMJ, inhibition of acetylcholinesterase can increase CHOLINERGIC receptor activity elsewhere leading to side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side Effects of Acetylcholinesterase Inhibitors:

Cardiovascular

A

CV System: the predominant muscarinic effect on the heart is vagal like bradycardia that can progress to sinus arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side Effects of Acetylcholinesterase Inhibitors:

Pulmonary

A

Pulmonary Receptors: muscarinic stim can result in bronchospasm and increased respiratory secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side Effects of Acetylcholinesterase Inhibitors:

Cerebral

A

Cerebral receptors: Physostigmine is a cholinesterase inhibitor that can cross the BBB. It can diffuse activation of the EEG by stimulating muscarinic and nicotinic receptors within the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side Effects of Acetylcholinesterase Inhibitors:

GI

A

GI Receptors:

muscarinic stim increases peristaltic activity - esophageal, gastric, and intestinal;

Glandular secretions - salivary and parietal

Periooperative bowel anastomotic leakage

Nausea and vomiting

Fecal incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neostigmine: Mechanism of Action

A

acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Neostigmine: Dosage

A

up to 0.08 mg/kg in children

5 mg in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Neostigmine: Onset

A

effects apparent in 5-10 mins

peak at 10 minutes and last more than 1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Neostigmine: Clinical Note

A

typically administered with glycopyrrolate to prevent bradycardia

20
Q

Neostigmine: Structure

A

carbamate moiety - binds to acetylcholinesterase

quaternary ammonium group - prevents passage across BBB

21
Q

Pyridostigmine: Mechanism of Action

A

acetylcholinesterase inhibitor

22
Q

Pyridostigmine: Dosage

A

up to 0.4 mg/kg in children

20 mg in adults

23
Q

Pyridostigmine: Onset

A

effects apparent in 10-15 mins and lasts more than 2 hours

24
Q

Pyridostigmine: Clinical Note

A

typically admin with glycopyrrolate to prevent bradycardia

25
Q

Pyridostigmine: Structure

A

carbamate moiety - binds to actylcholinesterase

quaternary ammonium incorporated into PHENOL ring - prevents passage across BBB

26
Q

Edrophonium: Mechanism of Action

A

acetylcholinesterase inhibitor

27
Q

Edrophonium: Dosage

A

0.5 - 1 mg/kg

28
Q

Edrophonium: Onset

A

most rapid onset and shortest duration for class. effects apparent in 1-2 mins. higher dosages last up to 1 hour.

29
Q

Edrophonium: Clinical Note

A

typically administered with atropine to prevent bradycardia.

If used with glycopyrrolate, should be given several minutes after glycol so that onset time matches

30
Q

Edrophonium: structure

A

noncovalent binding to acetylcholinesterase

Quaternary ammonium group - prevents passage across BBB

31
Q

Physostigmine: Mechanism of Action

A

Acetylcholinesterase inhibitor

32
Q

Physostigmine: Dosage

A

0.01 - 0.03 mg/kg

33
Q

Physostigmine: Clinical Note

A

can be used to treat anticholinergic toxicity from scopolamine or atropine overdose

also reverses some of the CNS depression from benzodiazapines and volatile anesthetics

34
Q

Physostigmine: Structure

A

carbamate moiety.

lack of quaternary ammonium allows passage across the BBB

35
Q

Which cholinesterase inhibitor allows passage across the BBB?

A

Physostigmine - b/c it lacks the quaternary ammonium group

36
Q

Sugammadex: Mechanism of Action

A

hydrophobic structural interactions trap aminosteroid NMBA (rocuronium, vecuronium) within CYCLODEXTRIN cavity, terminating NMB

37
Q

Suggamadex: Dosage

A

4 - 8 mg/kg

38
Q

Suggamadex: onset

A

can reverse shallow and deep NMB within 2 mins

39
Q

Suggamadex: Clinical Note

A

b/c of concerns about hypersensitivity and allergic reactions, not yet approved by US FDA

currently available in Europe

40
Q

Suggamadex: Structure

A

Modified cyclodextrin

41
Q

L-Cysteine: Mechanism of Action

A

combines with gantacurium to form less active degradation products

42
Q

L-Cysteine: Dosage

A

10-50 mg/kg

43
Q

L-Cysteine: Clinical Note

A

Still in investigative stages

44
Q

L-Cysteine: Structure

A

an endogenous amino acid

45
Q

The parasympathetic nervous system uses acetylcholine where?

A

As a PREganglionic and POSTganglionic NT

46
Q

Nicotinic receptors are blocked by_______

Muscarinic receptors are blocked by _________

A

Muscle relaxants (NMBAs)

Anticholinergic drugs (ex: atropine)

47
Q

Nicotine stimulates _______

Muscarine activates _______

A

Autonomic ganglia and skeletal muscle receptors (nicotinic receptors)

End organ effector cells in bronchial smooth muscle, salivary glands and SA node (Muscarinic receptors)